109 related articles for article (PubMed ID: 35809269)
1. Mortality Risk factors and SOX2 and mTOR expression in Patients with Esophageal Cancer.
Yu G; Yuexin Y; Yin L; Yiyin Z; Mei K; Liyang Z; Lei X; Fan W
Cell Mol Biol (Noisy-le-grand); 2022 Jan; 67(4):346-357. PubMed ID: 35809269
[TBL] [Abstract][Full Text] [Related]
2. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
[TBL] [Abstract][Full Text] [Related]
3. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
4. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
Gen Y; Yasui K; Nishikawa T; Yoshikawa T
Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
6. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2.
Wang Z; Qiao Q; Chen M; Li X; Wang Z; Liu C; Xie Z
FEBS Lett; 2014 Mar; 588(6):915-21. PubMed ID: 24508466
[TBL] [Abstract][Full Text] [Related]
7. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
Gao H; Teng C; Huang W; Peng J; Wang C
Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
[TBL] [Abstract][Full Text] [Related]
8. Sox2 induces tumorigenesis and angiogenesis of early-stage esophageal squamous cell carcinoma through secretion of Suprabasin.
Takahashi K; Asano N; Imatani A; Kondo Y; Saito M; Takeuchi A; Jin X; Saito M; Hatta W; Asanuma K; Uno K; Koike T; Masamune A
Carcinogenesis; 2020 Nov; 41(11):1543-1552. PubMed ID: 32055838
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
[TBL] [Abstract][Full Text] [Related]
10. P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.
van Olphen SH; Biermann K; Shapiro J; Wijnhoven BP; Toxopeus EL; van der Gaast A; Stoop HA; van Lanschot JJ; Spaander MC; Bruno MJ; Looijenga LH
Ann Surg; 2017 Feb; 265(2):347-355. PubMed ID: 28059963
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
[TBL] [Abstract][Full Text] [Related]
12. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
[TBL] [Abstract][Full Text] [Related]
13. Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency.
Wang S; Xia P; Ye B; Huang G; Liu J; Fan Z
Cell Stem Cell; 2013 Nov; 13(5):617-25. PubMed ID: 24209762
[TBL] [Abstract][Full Text] [Related]
14. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Wang Q; He W; Lu C; Wang Z; Wang J; Giercksky KE; Nesland JM; Suo Z
Anticancer Res; 2009 Apr; 29(4):1233-41. PubMed ID: 19414369
[TBL] [Abstract][Full Text] [Related]
15. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY
Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma.
Jiang Q; Chen J; Zhang B; Niu J; He Y
Med Sci Monit; 2017 Jun; 23():3200-3208. PubMed ID: 28665915
[TBL] [Abstract][Full Text] [Related]
17. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study.
Wani S; Drahos J; Cook MB; Rastogi A; Bansal A; Yen R; Sharma P; Das A
Gastrointest Endosc; 2014 Feb; 79(2):224-232.e1. PubMed ID: 24060519
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.
Tasioudi KE; Sakellariou S; Levidou G; Theodorou D; Michalopoulos NV; Patsouris E; Korkolopoulou P; Saetta AA
APMIS; 2015 Aug; 123(8):639-47. PubMed ID: 25912437
[TBL] [Abstract][Full Text] [Related]
19. Effect of neoadjuvant chemoradiotherapy on p53 and SOX2 protein expression in esophageal adenocarcinoma.
Suzuki L; Nieboer D; van Lanschot JJ; Spaander MC; Looijenga LH; Biermann K
Biomark Med; 2020 Jun; 14(9):785-793. PubMed ID: 32677456
[No Abstract] [Full Text] [Related]
20. [Clinical significance of the expression of eukaryotic initiation factor 4 E and mammalian target of rapamycin in esophageal squamous carcinoma tissues].
Lu J; Pan Y; Lei Y; Gu Y; Zhong F
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):905-8. PubMed ID: 26404688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
